type |
Ex - Dividend Date |
payment date |
value |
|---|---|---|---|
| Dividends | 12/22/2025 | 12/29/2025 | 0.65544000 |
| Dividends | 12/20/2024 | 12/27/2024 | 0.24000000 |
| Dividends | 12/21/2023 | 12/29/2023 | 0.08230000 |
| Dividends | 12/21/2017 | 12/27/2017 | 0.29724000 |
| Dividends | 12/23/2015 | 12/29/2015 | 0.14733000 |
| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
|
First Tracks Biotherapeutics
|
TRAX | Stock | Healthcare | US$ 1.52 B | 1,45% |
| AMLX | Stock | Healthcare | US$ 3.78 B | 1,44% | |
| XNCR | Stock | Healthcare | US$ 1.98 B | 1,41% | |
| ABCL | Stock | Healthcare | US$ 3.75 B | 1,34% | |
| MNPR | Stock | Healthcare | US$ 789.08 M | 1,23% | |
| ATAI | Stock | Healthcare | US$ 2.72 B | 1,17% | |
| REPL | Stock | Healthcare | US$ 1.42 B | 1,10% | |
| QURE | Stock | Healthcare | US$ 3.09 B | 1,08% | |
|
MBX Biosciences, Inc. Common Stock
|
MBX | Stock | Healthcare | US$ 2.97 B | 1,07% |
| SLS | Stock | Healthcare | US$ 2.80 B | 1,05% | |
Immix Biopharma Inc
|
IMMX | Stock | Healthcare | US$ 984.56 M | 1,03% |
|
LB Pharmaceuticals Inc Common Stock
|
LBRX | Stock | Healthcare | US$ 1.53 B | 1,03% |
Alto Neuroscience, Inc.
|
ANRO | Stock | Healthcare | US$ 1.40 B | 1,02% |
| FDMT | Stock | Healthcare | US$ 812.09 M | 1,01% | |
Zenas BioPharma, Inc. Common Stock
|
ZBIO | Stock | Healthcare | US$ 2.14 B | 1,01% |
| CGEM | Stock | Healthcare | US$ 1.34 B | 0,99% | |
| VOR | Stock | Healthcare | US$ 1.31 B | 0,98% | |
| ORIC | Stock | Healthcare | US$ 1.32 B | 0,97% | |
|
Definium Therapeutics, Inc.
|
DFTX | Stock | Healthcare | US$ 5.11 B | 0,97% |
| NRIX | Stock | Healthcare | US$ 2.71 B | 0,96% | |
| ASMB | Stock | Healthcare | US$ 735.63 M | 0,96% | |
| CADL | Stock | Healthcare | US$ 992.45 M | 0,94% | |
| ACHV | Stock | Healthcare | US$ 855.12 M | 0,93% | |
| MGTX | Stock | Healthcare | US$ 1.33 B | 0,92% | |
| IMNM | Stock | Healthcare | US$ 3.08 B | 0,92% | |
Apogee Therapeutics, Inc. Common Stock
|
APGE | Stock | Healthcare | US$ 10.20 B | 0,92% |
SpyGlass Pharma, Inc.
|
SGP | Stock | Healthcare | US$ 10.72 B | 0,91% |
| SANA | Stock | Healthcare | US$ 1.17 B | 0,89% | |
| VRDN | Stock | Healthcare | US$ 2.60 B | 0,88% | |
| RGNX | Stock | Healthcare | US$ 607.32 M | 0,87% | |
Biohaven Ltd.
|
BHVN | Stock | Healthcare | US$ 2.37 B | 0,87% |
Janux Therapeutics Inc
|
JANX | Stock | Healthcare | US$ 1.21 B | 0,87% |
Palvella Therapeutics, Inc
|
PVLA | Stock | Healthcare | US$ 2.24 B | 0,86% |
| SLDB | Stock | Healthcare | US$ 1.10 B | 0,86% | |
| KYMR | Stock | Healthcare | US$ 9.65 B | 0,86% | |
| DSGN | Stock | Healthcare | US$ 940.60 M | 0,86% | |
| DYN | Stock | Healthcare | US$ 4.53 B | 0,86% | |
| IDYA | Stock | Healthcare | US$ 3.85 B | 0,86% | |
|
Jade Biosciences, Inc.
|
JBIO | Stock | Healthcare | US$ 1.26 B | 0,85% |
| RVMD | Stock | Healthcare | US$ 45.01 B | 0,85% | |
| RCKT | Stock | Healthcare | US$ 423.73 M | 0,85% | |
|
Damora Therapeutics, Inc.
|
DMRA | Stock | Healthcare | US$ 1.86 B | 0,84% |
| INBX | Stock | Healthcare | US$ 1.80 B | 0,84% | |
| VIR | Stock | Healthcare | US$ 1.93 B | 0,84% | |
| PRAX | Stock | Healthcare | US$ 9.82 B | 0,83% | |
|
Adlai Nortye Ltd. American Depositary Shares
|
ANL | Stock | Healthcare | US$ 966.61 M | 0,82% |
Oruka Therapeutics, Inc.
|
ORKA | Stock | Healthcare | US$ 6.13 B | 0,82% |
|
Neurogene Inc
|
NGNE | Stock | Healthcare | US$ 772.44 M | 0,81% |
| DNTH | Stock | Healthcare | US$ 5.91 B | 0,81% | |
|
Eliem Therapeutics Inc
|
ELYM | Stock | Healthcare | US$ 342.68 M | 0,81% |
GH Research PLC
|
GHRS | Stock | Healthcare | US$ 1.92 B | 0,81% |
|
Avalo Therapeutics Inc
|
AVTX | Stock | Healthcare | US$ 1.03 B | 0,81% |
CG Oncology, Inc. Common stock
|
CGON | Stock | Healthcare | US$ 6.88 B | 0,81% |
| IMVT | Stock | Healthcare | US$ 8.95 B | 0,79% | |
| PCVX | Stock | Healthcare | US$ 9.13 B | 0,79% | |
Spyre Therapeutics Inc.
|
SYRE | Stock | Healthcare | US$ 9.40 B | 0,79% |
| RLAY | Stock | Healthcare | US$ 4.33 B | 0,79% |
Average Investor10 user rating
4.0
(2 people)
Virtus LifeSci Biotech Clinical Trials ETF (United States) is an exchange-traded fund (ETF), with assets under management totaling $45.88 million.
Over the past 12 months, Virtus LifeSci Biotech Clinical Trials ETF recorded a return of 100.34%, with its price trading between $24.57 and $56.03 during the same period.
The ETF is traded under the ticker BBC.
The current price of BBC is $48.42. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
BBC is currently trading at $48.42, with a market capitalization of approximately $45.884.626,00. Over the past year, the ETF has delivered a 100.34% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in BBC through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol BBC, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, BBC has returned -11.09%, and 100.34% over the past year.
If you were to purchase 100 shares of BBC at the current price of $48.42, your total investment would be $4,842.00.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
